1-5 of 5
MJ Mant
Close
Sort by
Journal Articles

Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44

A Masellis-Smith, AR Belch, MJ Mant, EA Turley, LM Pilarski
Journal: Blood
Blood (1996) 87 (5): 1891–1899.
https://doi.org/10.1182/blood.V87.5.1891.1891
Published: 1996
Journal Articles

In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears in Blood 1995 Jun 1;85(11):3365]

PL Bergsagel, AM Smith, A Szczepek, MJ Mant, AR Belch, LM Pilarski
Journal: Blood
Blood (1995) 85 (2): 436–447.
https://doi.org/10.1182/blood.V85.2.436.436
Published: 1995
Journal Articles

Selective expression of CD45 isoforms defines CALLA+ monoclonal B- lineage cells in peripheral blood from myeloma patients as late stage B cells

GS Jensen, MJ Mant, AJ Belch, JR Berenson, BA Ruether, LM Pilarski
Journal: Blood
Blood (1991) 78 (3): 711–719.
https://doi.org/10.1182/blood.V78.3.711.711
Published: 1991
Journal Articles

Abnormal clonogenic potential of T cells from multiple myeloma patients

LM Pilarski, MJ Mant, BA Ruether, G Carayanniotis, D Otto, JF Krowka
Journal: Blood
Blood (1985) 66 (6): 1266–1271.
https://doi.org/10.1182/blood.V66.6.1266.1266
Published: 1985
Journal Articles

Pre-B cells in peripheral blood of multiple myeloma patients

LM Pilarski, MJ Mant, BA Ruether
Journal: Blood
Blood (1985) 66 (2): 416–422.
https://doi.org/10.1182/blood.V66.2.416.416
Published: 1985